Geron Corp
N/A
USD
N/A
N/A
...
Chart
Financials
Description
GERN Company Description
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
GERN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view GERN Smart Score
Score Breakdown
GERN Company Description
Show More
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of GERN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GERN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on GERN's company Twitter account
WallStreetBets
Number of mentions of GERN in WallStreetBets Daily Discussion
GERN News
Recent insights relating to GERN
CNBC Recommendations
Recent picks made for GERN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in GERN
Corporate Flights
Flights by private jets registered to GERN
Our Analysis